Cite Filings / SGHT / 0000950170-25-039015
Feed Companies Filings Check
Sign in
SCHEDULE 13D/A

Beneficial Ownership Report

Sight Sciences, Inc. · Filed 2025-03-13 · Acc 0000950170-25-039015

Documents 1

  • SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2025-03-13 4 Chief Financial Officer acquired 286,738 shares (grant or award)
  • 2025-03-13 4 Chief Legal Officer acquired 139,785 shares (grant or award)
  • 2025-03-13 4 Chief Technology Officer acquired 98,566 shares (grant or award)
  • 2025-03-13 4 Chief Commercial Officer acquired 172,043 shares (grant or award)
  • 2025-03-13 4 EVP, Research & Development bought 20,000 shares at an average $2.66 ($53,250)
  • 2025-03-13 SCHEDULE 13D/A Beneficial Ownership Report
  • 2025-03-13 4 Director acquired 513,000 shares (other)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…